TLR4 and necrotizing enterocolitis: Taken together, our findings show that C34 decreases the extent of LPS signaling in human tissue, and raises the exciting possibility that C34 represents a new therapeutic option in diseases associated with exaggerated TLR4 signaling, such as NEC.